Related Articles
Post‑radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma
Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR‑TKI treatment in advanced NSCLC
Clinical significance of BRAFV600E mutation in circulating tumor DNA in Chinese patients with melanoma
Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR‑TKIs in advanced non‑small‑cell lung cancer
Clinical and molecular assessment of regorafenib monotherapy